Federal Circuit denies Illumina’s writ request in Ariosa dispute
The US Court of Appeals for the Federal Circuit has said it won’t review a writ filed by Illumina and its subsidiary Verinata Health in a patent dispute with Ariosa Diagnostics.
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk
26 January 2018 A California jury has ordered Roche-owned Ariosa Diagnostics to pay US-based gene sequencing company Illumina $27 million in a patent dispute.
26 January 2018 A California jury has ordered Roche-owned Ariosa Diagnostics to pay US-based gene sequencing company Illumina $27 million in a patent dispute.
26 January 2018 A California jury has ordered Roche-owned Ariosa Diagnostics to pay US-based gene sequencing company Illumina $27 million in a patent dispute.